Bartl K, Dorsch E, Lill H, Ziegenhorn J
Thromb Haemost. 1980 Feb 29;42(5):1446-51.
We describe a new method for determining the biological activity of heparin in plasma with use of thrombin and the substrate Tos-Gly-Pro-Arg-pNA. The procedure is based on the photometric determination of the inactivation of thrombin after incubation with plasma in the presence of endogenous antithrombin III (At III). The method allows the specific determination of heparin concentrations from 0.02 USP to 0.8 USP/ml of plasma in the presence of normal At III levels. It has been carried out manually by use of an Eppendorf spectrum line photometer or automatically by use of a Vitatron Akes analyzer. For evaluation, the results were compared with two standard samples which contained heparin in the low and high therapeutic range, respectively.
我们描述了一种利用凝血酶和底物甲苯磺酰甘氨酰脯氨酰精氨酸对硝基苯胺(Tos-Gly-Pro-Arg-pNA)来测定血浆中肝素生物活性的新方法。该程序基于在存在内源性抗凝血酶III(At III)的情况下,将血浆与凝血酶孵育后通过光度法测定凝血酶的失活情况。该方法能够在正常At III水平下,从0.02 USP至0.8 USP/ml血浆中特异性地测定肝素浓度。它既可以使用艾本德光谱线光度计手动进行,也可以使用维塔龙·阿克斯分析仪自动进行。为了进行评估,将结果与两个分别含有低治疗范围和高治疗范围肝素的标准样品进行了比较。